Patents Assigned to Daninippon Sumitomo Pharma Co., Ltd
  • Publication number: 20120077768
    Abstract: The present invention provides a lyophilized amrubicin formulation and a process thereof. In the process, the concentration of the aqueous solution before lyophilization is controlled to about 7.5 mg(potency)/mL or more. Thus, the formulation decreases the production of desaccharified compound and is stable to storage for a long period. The formulation is useful as a cancer chemotherapeutic agent.
    Type: Application
    Filed: May 27, 2009
    Publication date: March 29, 2012
    Applicant: Daninippon Sumitomo Pharma Co., Ltd
    Inventors: Hajimu Hirofuji, Hotaka Hashimoto, Kazunaria Tanaka